Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ole Jørgen Scheie Lygren"'
Autor:
Siv-Elin Leirvaag Carlsen, Katja Isaksen, Lars Thore Fadnes, Ole Jørgen Scheie Lygren, Anne Nordrehaug Åstrøm
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background People with substance use disorders often have poor oral health, which can negatively impact their quality of life. Since 2005, patients receiving opioid maintenance treatment (OMT) in Norway have been eligible for free oral healt
Externí odkaz:
https://doaj.org/article/0d5ceb36145549dc8b029a18269d25af
Publikováno v:
Tidsskrift for velferdsforskning, Vol 22, Pp 228-239 (2019)
Artikkelen belyser hvordan etterlatte ved narkotikarelaterte dødsfall opplever møtet med hjelpeapparatet, og hvordan fagfolk som møter de etterlatte, kan bidra til å øke eller minske den opplevde stigmatiseringen av dem. Bakgrunnen for artikkele
Externí odkaz:
https://doaj.org/article/093b86e3a139431ba54e071d7ff7696a
Autor:
Lars Thore Fadnes, Anne Nordrehaug Åstrøm, Ole Jørgen Scheie Lygren, Katja Isaksen, Siv-Elin Leirvaag Carlsen
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy
Substance Abuse Treatment, Prevention, and Policy, Vol 16, Iss 1, Pp 1-12 (2021)
Substance Abuse Treatment, Prevention, and Policy, Vol 16, Iss 1, Pp 1-12 (2021)
BackgroundPeople with substance use disorders often have poor oral health, which can negatively impact their quality of life. Since 2005, patients receiving opioid maintenance treatment (OMT) in Norway have been eligible for free oral health care ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af740efac847a36bd0ec428626654c3d
https://doi.org/10.1186/s13011-021-00379-6
https://doi.org/10.1186/s13011-021-00379-6
Autor:
Svetlana Skurtveit, Christian Ohldieck, Olav Dalgard, Rafael Alexander Leiva, Peter Vickerman, Else-Marie Løberg, Lars Thore Fadnes, Jørn Henrik Vold, Håvard Midgard, Ole Jørgen Scheie Lygren, Kjell Arne Johansson, Fatemeh Chalabianloo, Christer Frode Aas
Publikováno v:
Nature Methods
Fadnes, L T, Aas, C F, Vold, J H, Leiva, R A, Ohldieck, C, Chalabianloo, F, Skurtveit, S, Lygren, O J, Dalgård, O, Vickerman, P T, Midgard, H, Løberg, E M, Johansson, K A & Lim, A G 2021, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : A multicenter randomized controlled trial (INTRO-HCV) ', PLoS Medicine, vol. 18, no. 6, 1003653 . https://doi.org/10.1371/journal.pmed.1003653
PLoS Medicine
e1003653
Plos Medicine
PLoS Medicine, Vol 18, Iss 6, p e1003653 (2021)
Fadnes, L T, Aas, C F, Vold, J H, Leiva, R A, Ohldieck, C, Chalabianloo, F, Skurtveit, S, Lygren, O J, Dalgård, O, Vickerman, P T, Midgard, H, Løberg, E M, Johansson, K A & Lim, A G 2021, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : A multicenter randomized controlled trial (INTRO-HCV) ', PLoS Medicine, vol. 18, no. 6, 1003653 . https://doi.org/10.1371/journal.pmed.1003653
PLoS Medicine
e1003653
Plos Medicine
PLoS Medicine, Vol 18, Iss 6, p e1003653 (2021)
Background The standard pathways of testing and treatment for hepatitis C virus (HCV) infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID). The aim of this study was to evaluate the efficacy of integrated treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4083ee7e462ccc1aa36cac585b65f08f
https://hdl.handle.net/11250/3009523
https://hdl.handle.net/11250/3009523
Autor:
Kjell Arne Johansson, Vibeke Bråthen Buljovcic, Martine Bonnier, Ole Jørgen Scheie Lygren, Else-Marie Løberg, Lars Thore Fadnes, Ronny Bjørnestad
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Background For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV, and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd76af559463a03e7df3268c1662d7b
https://doi.org/10.1186/s13011-019-0245-y
https://doi.org/10.1186/s13011-019-0245-y
Autor:
Håvard Midgard, Kjell Arne Johansson, Christian Ohldieck, Lars Thore Fadnes, Rafael Alexander Mo Leiva, Fatemeh Chalabianloo, Peter Vickerman, Olav Dalgard, Svetlana Skurtveit, Jørn Henrik Vold, Else-Marie Løberg, Christer Frode Aas, Ole Jørgen Scheie Lygren
Publikováno v:
BMC Infectious Diseases
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
19:943
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
19:943
Background A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance use disorder treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f306d442ea3e9249dc76b5005b9b93
https://pubmed.ncbi.nlm.nih.gov/31703669
https://pubmed.ncbi.nlm.nih.gov/31703669